NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Postmarketing Surveillance Study for Quadrivalent Influenza Vaccine (VaxigripTetra®) in Subjects Aged 6 to 35 Months

CompletedN/A

Sponsor: Sanofi

Conditions: Influenza

Interventions: VaxigripTetra®

Countries: South Korea

Multi-center, observational, active safety surveillance study in participants aged 6 to 35 months in Korea under routine clinical practices.

Eligibility overview

Sex: ALL

Age: 6 Months to 35 Months

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Aged 6 to 35 months on the day of enrolment
* Informed consent form has been signed and dated by the parent or other legally acceptable representative
* Receipt of one dose of VaxigripTetra® on the day of inclusion in routine practice according to the approved local product insert

Exclusion Criteria:

\- Participation at the time of study enrolment (or in the 4 weeks preceding the enrolment) or planned participation during the present study period in a clinical study investigating a vaccine, drug, medical device, or medical procedure

Locations (12)

Gangwon-do, South Korea
Gwangju, South Korea
Gyeonggi-do, South Korea
Gyeonggi-do, South Korea
Gyeonggi-do, South Korea
Gyeonggi-do, South Korea
Gyeonggi-do, South Korea
Gyeongsangnam-do, South Korea
Gyeongsangnam-do, South Korea
Seoul, South Korea
Seoul, South Korea
Seoul, South Korea